Manila Bulletin
Sinovac must answer Senate queries on vaccine efficacy, safety --- Sen. Hontiveros
Senator Risa Hontiveros is calling for Sinovac Biotech to send a representative to a Senate hearing to address concerns about its COVID-19 vaccine.
Hontiveros stated that the Senate should not approve the P74 billion budget for vaccines until Sinovac provides sufficient data and satisfactory information regarding the safety of its vaccine.
The opposition senator emphasized the need to hear directly from Sinovac about the vaccine's efficacy, potential side effects, and cost.
Hontiveros expressed skepticism towards conflicting statements from the Palace and the National Task Force on COVID-19 regarding Sinovac, questioning the integrity of their claims.
She highlighted that public distrust extends beyond senators, with ordinary citizens also harboring doubts about the vaccine.
Additionally, Hontiveros raised the issue of Sinovac's alleged past bribery incidents, as reported by the Washington Post.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippine Senate will resume its inquiry into the government's COVID-19 immunization program this Friday, January 22, to address lingering questions regarding vaccine pricing and efficacy.
Read more →
Two senators are advocating for another hearing on the Philippines' COVID-19 vaccination rollout due to unresolved issues.
Read more →
Sinovac Biotech general manager Helen Yang expressed confidence in the safety profile of CoronaVac, stating that no serious adverse reactions have been reported so far.
Read more →
Senator Panfilo Lacson denied accusations that senators were politicizing the government's COVID-19 vaccine procurement process.
Read more →
Senator Panfilo Lacson expressed suspicion of an attempt to overprice Sinovac COVID-19 vaccines in the Philippines, noting a significant price difference compared to other countries.
Read more →